Companies / Santa Cruz Biotechnology / CD43 (DF-T1) FITC
Santa Cruz Biotechnology

CD43 (DF-T1) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG1; CD43 Antibody (DF-T1) is an IgG1 κ mouse monoclonal CD43 antibody (also designated CD43 antibody) that detects the CD43 protein of human origin by WB, IP, IF, IHC(P) and FCM. CD43 Antibody (DF-T1) is available as both the non-conjugated anti-CD43 antibody form, as well as multiple conjugated forms of anti-CD43 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Over 100 cell surface markers have been identified through the use of monoclonal antibodies. Many of these markers have proven useful in identifying a specific subpopulation of cells within a mixed colony. Accordingly, these molecules have been assigned a "cluster of differentiation" (CD) designation. CD43 is the major O-glycosylated cell-surface associated sialoglycoprotein found on the cell membranes of leukocytes. It is a member of the surface mucin family which plays a central role in cellular adhesion tumor progression. Also called leukosialin, CD43 is best known as a marker for identifying normal and neoplastic T cells and a subset of neoplastic B cells within tissues. CD43 is thought to function as a negative regulator of cellular adhesion.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.